Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Equity Ratio: 2010-2024

Historic Equity Ratio for OptimizeRx (OPRX) over the last 15 years, with FY2024 value amounting to 0.68.

  • OptimizeRx's Equity Ratio rose 360.04% to 0.72 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18, marking a year-over-year increase of 984.98%. This contributed to the annual value of 0.68 for FY2024, which is 95.76% down from last year.
  • Per OptimizeRx's latest filing, its Equity Ratio stood at 0.68 for FY2024, which was down 95.76% from 0.69 recorded in FY2023.
  • In the past 5 years, OptimizeRx's Equity Ratio registered a high of 0.94 during FY2022, and its lowest value of 0.68 during FY2024.
  • In the last 5 years, OptimizeRx's Equity Ratio had a median value of 0.83 in 2020 and averaged 0.81.
  • As far as peak fluctuations go, OptimizeRx's Equity Ratio soared by 1249.38% in 2021, and later plummeted by 2631.28% in 2023.
  • Over the past 5 years, OptimizeRx's Equity Ratio (Annual) stood at 0.83 in 2020, then rose by 12.49% to 0.93 in 2021, then increased by 0.51% to 0.94 in 2022, then fell by 26.31% to 0.69 in 2023, then dropped by 0.96% to 0.68 in 2024.
  • Its Equity Ratio was 0.68 in FY2024, compared to 0.69 in FY2023 and 0.94 in FY2022.